MedPath

Copeptin, Pro-Atrial Natriuretic Peptide (Pro-ANP) and Pro-Adrenomedullin (Pro-ADM) as markers of hypoxic stress in patients with obstructive sleep apnoea syndrome (OSAS)

Completed
Conditions
Obstructive sleep apnoea syndrome (OSAS)
Respiratory
Sleep disorders
Registration Number
ISRCTN02302064
Lead Sponsor
niversity Hospital Basel (Switzerland)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
300
Inclusion Criteria

1. Patients aged 18 or older
2. Patients with suspicion of obstructive sleep apnoea syndrome or central apnoea events

Exclusion Criteria

1. Mental disorder preventing appropriate judgment concerning study participation
2. Significant co morbidity resulting in reduced life expectancy (lower than 6 months)
3. Planned emigration or relocation within the country during the study period
4. Pregnancy and breast-feeding

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath